
A new study reports the 25-year mortality follow-up of 838 patients randomized to partial ileal bypass surgery and diet instruction, or diet instruction alone (control) to evaluate surgical treatment for hyperlipidemia. In the study by Buchwald et al., 2010, patients in the treatment group experienced a 1.0 year overall higher life expectancy over 25 years of follow-up. In the cohort with an ejection fraction greater than or equal to 50%, overall life expectancy in the treatment group was 1.7 years greater. Although LDL-cholesterol levels were not reported in this study, the authors reported greater cholesterol lowering in the treatment group. Thus, their findings provide further support for long-term longevity associated with aggressive lipid lowering interventions.